| Authors Key Contacts | |
|---|---|
| Issue | Mar-2026 |
| Practice Areas | |
| Industries | Food and BeverageMedical, Pharmaceutical, Healthcare, Life Science and BiotechnologyChemical |
Newsletter "Life Science Newsletter (March 2026)" has been published.
Contents
Conditional approval for regenerative medicine products
I. Regenerative medicine products
- Definition
- Framework of regulation
- Supplement —the Act on the Safety of Regenerative Medicine—
II. Conditional and time‑limited approval
- Overview of the system
- Supplement —conditional approval for pharmaceuticals—